Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Evaluation of a Multidisciplinary Team Delivered Deprescribing Intervention for Patients With Chronic Kidney Disease in Qatar: A Randomized Controlled Trial

NCT06324045 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.

NCT NCT06324045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06324045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Evaluation of a Multidisciplinary Team Delivered Deprescribing Intervention for Patients With Chronic Kidney Disease in Qatar: A Randomized Controlled Trial
Lead sponsor
Hamad Medical Corporation
Phase
Not applicable
Overall status
Recruiting
Start date
February 19, 2024
Completion date
March 31, 2026
Enrollment
424 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases